Barclays Maintains Equal-Weight on PolyPid, Raises Price Target to $10
Portfolio Pulse from Benzinga Newsdesk
Barclays analyst Balaji Prasad has maintained an Equal-Weight rating on PolyPid (NASDAQ:PYPD) and raised the price target from $2.5 to $10.
October 23, 2023 | 2:46 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Barclays has maintained an Equal-Weight rating on PolyPid and raised the price target from $2.5 to $10, which could potentially lead to an increase in the stock's price.
The increase in price target by Barclays from $2.5 to $10 indicates a positive outlook for PolyPid. This could lead to increased investor confidence and potentially an increase in the stock's price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100